These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37512579)

  • 1. Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review.
    Perazzoli G; García-Valdeavero OM; Peña M; Prados J; Melguizo C; Jiménez-Luna C
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics.
    Martín-Blázquez A; Jiménez-Luna C; Díaz C; Martínez-Galán J; Prados J; Vicente F; Melguizo C; Genilloud O; Pérez Del Palacio J; Caba O
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32325731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique urinary metabolomic signature for the detection of pancreatic ductal adenocarcinoma.
    Sahni S; Pandya AR; Hadden WJ; Nahm CB; Maloney S; Cook V; Toft JA; Wilkinson-White L; Gill AJ; Samra JS; Dona A; Mittal A
    Int J Cancer; 2021 Mar; 148(6):1508-1518. PubMed ID: 33128797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Metabolite Biomarkers for Early Detection of Stage-I Pancreatic Ductal Adenocarcinoma.
    Cao Y; Zhao R; Guo K; Ren S; Zhang Y; Lu Z; Tian L; Li T; Chen X; Wang Z
    Front Oncol; 2021; 11():744667. PubMed ID: 35127469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for pancreatic cancer based on tissue and serum metabolomics analysis in a multicenter study.
    Zhao R; Ren S; Li C; Guo K; Lu Z; Tian L; He J; Zhang K; Cao Y; Liu S; Li D; Wang Z
    Cancer Med; 2023 Feb; 12(4):5158-5171. PubMed ID: 36161527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding metabolomic characteristics of pancreatic ductal adenocarcinoma by HR-MAS NMR detection of pancreatic tissues.
    Wang S; Wen S; Guo P; Liu H; Feng J; Huang H
    J Pharm Biomed Anal; 2020 Oct; 190():113546. PubMed ID: 32846403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
    Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
    Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma.
    Mahajan UM; Alnatsha A; Li Q; Oehrle B; Weiss FU; Sendler M; Distler M; Uhl W; Fahlbusch T; Goni E; Beyer G; Chromik A; Bahra M; Klein F; Pilarsky C; Grützmann R; Lerch MM; Lauber K; Christiansen N; Kamlage B; Regel I; Mayerle J
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review on metabolomics-based diagnostic biomarker discovery and validation in pancreatic cancer.
    Long NP; Yoon SJ; Anh NH; Nghi TD; Lim DK; Hong YJ; Hong SS; Kwon SW
    Metabolomics; 2018 Aug; 14(8):109. PubMed ID: 30830397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary metabolite prognostic biomarker panel for pancreatic ductal adenocarcinomas.
    Hipperson L; Hadden WJ; Nahm CB; Gill AJ; Samra JS; Dona A; Mittal A; Sahni S
    Biochim Biophys Acta Gen Subj; 2021 Nov; 1865(11):129966. PubMed ID: 34329704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis.
    Kane LE; Mellotte GS; Mylod E; O'Brien RM; O'Connell F; Buckley CE; Arlow J; Nguyen K; Mockler D; Meade AD; Ryan BM; Maher SG
    Cancer Res Commun; 2022 Oct; 2(10):1229-1243. PubMed ID: 36969742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need.
    Liou GY; Byrd CJ
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37173913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
    LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
    BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine.
    Phua LC; Goh S; Tai DWM; Leow WQ; Alkaff SMF; Chan CY; Kam JH; Lim TKH; Chan ECY
    Cancer Chemother Pharmacol; 2018 Feb; 81(2):277-289. PubMed ID: 29196965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic ductal adenocarcinoma is associated with a distinct urinary metabolomic signature.
    Davis VW; Schiller DE; Eurich D; Bathe OF; Sawyer MB
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S415-23. PubMed ID: 23096698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study.
    Borgmästars E; Ulfenborg B; Johansson M; Jonsson P; Billing O; Franklin O; Lundin C; Jacobson S; Simm M; Lubovac-Pilav Z; Sund M
    Transl Oncol; 2024 Jul; 48():102059. PubMed ID: 39018772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer early detection: expanding higher-risk group with clinical and metabolomics parameters.
    Urayama S
    World J Gastroenterol; 2015 Feb; 21(6):1707-17. PubMed ID: 25684935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD63-positive extracellular vesicles are potential diagnostic biomarkers of pancreatic ductal adenocarcinoma.
    Odaka H; Hiemori K; Shimoda A; Akiyoshi K; Tateno H
    BMC Gastroenterol; 2022 Mar; 22(1):153. PubMed ID: 35350978
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.